Arvinas Holding Company (ARVN) Receives a Hold from Bank of America Securities

Bank of America Securities analyst Tazeen Ahmad maintained a Hold rating on Arvinas Holding Company today and set a price target of $12.00. The company’s shares opened today at $9.92.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Ahmad is an analyst with an average return of -2.2% and a 50.10% success rate. Ahmad covers the Healthcare sector, focusing on stocks such as Ascendis Pharma, Sarepta Therapeutics, and PTC Therapeutics.

In addition to Bank of America Securities, Arvinas Holding Company also received a Hold from BMO Capital’s Evan Seigerman in a report issued on September 30. However, today, Barclays maintained a Buy rating on Arvinas Holding Company (NASDAQ: ARVN).

The company has a one-year high of $29.61 and a one-year low of $5.90. Currently, Arvinas Holding Company has an average volume of 1.97M.

Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ARVN in relation to earlier this year. Last month, Briggs Morrison, a Director at ARVN bought 30,000.00 shares for a total of $226,800.00.